Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2. [PDF]
De Pasquale V+4 more
europepmc +1 more source
Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma. [PDF]
Alshehri MA+4 more
europepmc +1 more source
The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology. [PDF]
Mah D+7 more
europepmc +1 more source
A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors. [PDF]
Klein K+7 more
europepmc +1 more source
Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation. [PDF]
Song L+4 more
europepmc +1 more source
Coreceptor functions of cell surface heparan sulfate proteoglycans.
Hayashida K, Aquino RS, Park PW.
europepmc +1 more source
Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients. [PDF]
Grillo PK, Győrffy B, Götte M.
europepmc +1 more source
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration. [PDF]
Urbinati C+7 more
europepmc +1 more source
Heparan sulfate proteoglycans as targets for cancer therapy: a review. [PDF]
Onyeisi JOS+3 more
europepmc +1 more source
Fine-tuning of Fgf8 morphogen gradient by heparan sulfate proteoglycans in the extracellular matrix. [PDF]
Gupta M+6 more
europepmc +1 more source